𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Living donor liver transplantation and hepatitis C

✍ Scribed by Lisa M. Forman; James F. Trotter; Jean Emond


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
48 KB
Volume
10
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Outcomes in hepatitis C virus–infected r
✍ Norah A. Terrault; Mitchell L. Shiffman; Anna S.F. Lok; Sammy Saab; Lan Tong; Ro πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 1 views

In this retrospective study of hepatitis C virus (HCV)-infected transplant recipients in the 9-center Adult to Adult Living Donor Liver Transplantation Cohort Study, graft and patient survival and the development of advanced fibrosis were compared among 181 living donor liver transplant (LDLT) recip

Histologic recurrence of chronic hepatit
✍ Mitchell L. Shiffman; R. Todd Stravitz; Melissa J. Contos; A. Scott Mills; Richa πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We

Is severe recurrent hepatitis C more com
✍ Mark W. Russo; Roshan Shrestha πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## No differences between LDLT and DD Shiffman 1 23 USA, single center yes No patients developed cirrhosis on liver biopsy @ 3 years Russo 10 279 USA, UNOS database no 2-year graft survival 72% LDLT and 75% DD Bozorgzadeh 11 35 USA, single center no No difference in HCV recurrence on liver biopsy

Living donor liver transplantation for h
✍ Linsheng Guo; Mauricio Orrego; Hector Rodriguez-Luna; Vijiyan Balan; Thomas Byrn πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 181 KB πŸ‘ 1 views

The question of possible earlier and more aggressive recurrence of hepatitis C virus (HCV) infection after living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) remains unanswered. To address this issue we retrospectively reviewed virological, histological